Editorial
doi: 10.1056/NEJM199905273402110.
Residual HIV-1 disease in the era of highly active antiretroviral therapy
- PMID: 10341281
- DOI: 10.1056/NEJM199905273402110
Item in Clipboard
Editorial
Residual HIV-1 disease in the era of highly active antiretroviral therapy
N Engl J Med.
.
No abstract available
Comment on
-
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.N Engl J Med. 1999 May 27;340(21):1605-13. doi: 10.1056/NEJM199905273402101. N Engl J Med. 1999. PMID: 10341272 Clinical Trial.
-
Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.N Engl J Med. 1999 May 27;340(21):1614-22. doi: 10.1056/NEJM199905273402102. N Engl J Med. 1999. PMID: 10341273 Clinical Trial.
Similar articles
-
Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.N Engl J Med. 1999 May 27;340(21):1614-22. doi: 10.1056/NEJM199905273402102. N Engl J Med. 1999. PMID: 10341273 Clinical Trial.
-
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.N Engl J Med. 1999 May 27;340(21):1605-13. doi: 10.1056/NEJM199905273402101. N Engl J Med. 1999. PMID: 10341272 Clinical Trial.
-
Antiretroviral resistance.J HIV Ther. 2006 Dec;11(4):72-3. J HIV Ther. 2006. PMID: 17578209 No abstract available.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Primary HIV infection in infants: impact of highly active antiretroviral therapy on the natural course.J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):53-7. J Biol Regul Homeost Agents. 2002. PMID: 12003175 Review.
Cited by
-
Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.Retrovirology. 2007 Aug 8;4:56. doi: 10.1186/1742-4690-4-56. Retrovirology. 2007. PMID: 17686171 Free PMC article.
-
In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months.J Virol. 2003 Feb;77(3):2271-5. doi: 10.1128/jvi.77.3.2271-2275.2003. J Virol. 2003. PMID: 12525664 Free PMC article.
-
Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients.Antimicrob Agents Chemother. 2003 Jan;47(1):238-43. doi: 10.1128/AAC.47.1.238-243.2003. Antimicrob Agents Chemother. 2003. PMID: 12499197 Free PMC article. Clinical Trial.
-
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.BMC Res Notes. 2014 Jan 21;7:52. doi: 10.1186/1756-0500-7-52. BMC Res Notes. 2014. Retraction in: BMC Res Notes. 2014 Nov 25;7:868. doi: 10.1186/1756-0500-7-868. PMID: 24447387 Free PMC article. Retracted. Clinical Trial.
-
Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients.J Neurovirol. 2006 Apr;12(2):100-7. doi: 10.1080/13550280600713932. J Neurovirol. 2006. PMID: 16798671
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
